Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Together, we can work through these challenges, and remember, you are not alone in this journey
Internationally, liraglutide is approved by the European Medicines Agency (EMA), the UK's Medicines and Healthcare products Regulatory Agency (MHRA), Health Canada, Australia's TGA, and regulatory bodies in numerous other countries
Previously, animal studies found that GLP-1 signaling is involved in taste sensitivity, particularly with sweet tastes
Several factors explain the lack of approval: insufficient clinical trials (no completed Phase 3 trials for most indications), safety concerns (FDA has identified specific adverse events), commercial considerations (patent status affects development investment), regulatory pathway (approval requires specific, rigorous documentation), and competition (Tesamorelin already approved for related indication)
